Your browser doesn't support javascript.
loading
Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America.
Orozco-Levi, Mauricio; Cáneva, Jorge; Fernandes, Caio; Restrepo-Jaramillo, Ricardo; Zayas, Nayeli; Conde, Rafael; Diez, Mirta; Jardim, Carlos; Pacheco Gallego, Manuel C; Melatini, Luciano; Valdéz, Héctor; Pulido, Tomás.
Afiliação
  • Orozco-Levi M; Respiratory Department Hospital Internacional de Colombia Bucaramanga Colombia.
  • Cáneva J; EMICON Research Group, MINCIENCIAS Bogotá Colombia.
  • Fernandes C; Universidad de Santander (UDES) Bucaramanga Colombia.
  • Restrepo-Jaramillo R; Red Colombiana de Hipertensión Pulmonar (HAPred.co) Colombia.
  • Zayas N; Respiratory Department Hospital Universitario Fundación Favaloro Buenos Aires Argentina.
  • Conde R; Pulmonary Division, Pulmonary Circulation Unit, Pulmonary Division, Heart Institute University of São Paulo Medical School São Paulo Brazil.
  • Diez M; University of South Florida Tampa Florida USA.
  • Jardim C; Cardiopulmonary Department National Heart Institute Mexico City Mexico.
  • Pacheco Gallego MC; Red Colombiana de Hipertensión Pulmonar (HAPred.co) Colombia.
  • Melatini L; Critical Medicine and Intensive Care, Pulmonology, Vascular Pulmonary Center Fundación Neumológica Colombiana Bogotá Colombia.
  • Valdéz H; Cardiology Department Instituto Cardiovascular Buenos Aires Buenos Aires Argentina.
  • Pulido T; Pulmonary Division, Pulmonary Circulation Unit, Pulmonary Division, Heart Institute University of São Paulo Medical School São Paulo Brazil.
Pulm Circ ; 12(1): e12012, 2022 Jan.
Article em En | MEDLINE | ID: mdl-35506085

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article